MSCE, Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, 262 Danny Thomas Pl, Mail Stop 735, Memphis, TN, USA.
J Clin Oncol. 2011 Aug 1;29(22):3056-64. doi: 10.1200/JCO.2011.34.6585. Epub 2011 Jun 27.
Childhood cancer survivors experience an increased incidence of subsequent neoplasms (SNs). Those surviving the first SN (SN1) remain at risk to develop multiple SNs. Because SNs are a common cause of late morbidity and mortality, characterization of rates of multiple SNs is needed.
In a total of 14,358 5-year survivors of childhood cancer diagnosed between 1970 and 1986, analyses were carried out among 1,382 survivors with an SN1. Cumulative incidence of second subsequent neoplasm (SN2), either malignant or benign, was calculated.
A total of 1,382 survivors (9.6%) developed SN1, of whom 386 (27.9%) developed SN2. Of those with SN2, 153 (39.6%) developed more than two SNs. Cumulative incidence of SN2 was 46.9% (95% CI, 41.6% to 52.2%) at 20 years after SN1. The cumulative incidence of SN2 among radiation-exposed survivors was 41.3% (95% CI, 37.2% to 45.4%) at 15 years compared with 25.7% (95% CI, 16.5% to 34.9%) for those not treated with radiation. Radiation-exposed survivors who developed an SN1 of nonmelanoma skin cancer (NMSC) had a cumulative incidence of subsequent malignant neoplasm (SMN; ie, malignancies excluding NMSC) of 20.3% (95% CI, 13.0% to 27.6%) at 15 years compared with only 10.7% (95% CI, 7.2% to 14.2%) for those who were exposed to radiation and whose SN1 was an invasive SMN (excluding NMSC).
Multiple SNs are common among aging survivors of childhood cancer. SN1 of NMSC identifies a population at high risk for invasive SMN. Survivors not exposed to radiation who develop multiple SNs represent a population of interest for studying genetic susceptibility to neoplasia.
儿童癌症幸存者发生继发肿瘤(SN)的几率增加。那些首次发生 SN(SN1)的幸存者仍有发生多个 SN 的风险。由于 SN 是导致晚期发病率和死亡率的常见原因,因此需要对多个 SN 的发生率进行特征描述。
在 1970 年至 1986 年间诊断出的 14358 名儿童癌症 5 年幸存者中,对 1382 名发生 SN1 的幸存者进行了分析。计算了第二例继发恶性或良性肿瘤(SN2)的累积发生率。
共有 1382 名幸存者(9.6%)发生了 SN1,其中 386 名(27.9%)发生了 SN2。在发生 SN2 的患者中,有 153 名(39.6%)发生了两个以上的 SN。SN1 后 20 年 SN2 的累积发生率为 46.9%(95%可信区间,41.6%至 52.2%)。接受过放射治疗的幸存者的 SN2 累积发生率为 15 年时的 41.3%(95%可信区间,37.2%至 45.4%),而未接受放射治疗的幸存者为 25.7%(95%可信区间,16.5%至 34.9%)。发生 SN1 非黑色素瘤皮肤癌(NMSC)的放射治疗暴露幸存者,其随后发生恶性肿瘤(即排除 NMSC 的恶性肿瘤)的累积发生率为 15 年时的 20.3%(95%可信区间,13.0%至 27.6%),而接受放射治疗且 SN1 为侵袭性恶性肿瘤(排除 NMSC)的幸存者的累积发生率仅为 10.7%(95%可信区间,7.2%至 14.2%)。
儿童癌症幸存者随着年龄的增长,多个 SN 较为常见。SN1 为 NMSC 可确定高危侵袭性恶性肿瘤人群。未接受放射治疗且发生多个 SN 的幸存者代表了研究肿瘤遗传易感性的一个重要人群。